Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hammersmith Medicines Research is one of the largest independent early-phase contract research organisations in Europe. Founded in London in 1993, it specializes in first-in-human and early phase clinical trials for pharmaceutical and biotechnology companies worldwide. The company operates purpose-built facilities with over 140 beds and offers comprehensive services from study design through to clinical study report. Accredited by the MHRA for all phases of phase I trials—including higher-risk studies—HMR has conducted more than 850 studies since inception. Its quality systems are certified to ISO standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hammersmith Medicines Research.